Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Annals of the American Thoracic Society · 2022
    JKJamuna KrishnanSBSamprit BanerjeeMMMonika M Safford
    PMID: 35657680PMCID: PMC9528745DOIFirst author17 citations
  2. 2
    Annals of the American Thoracic Society · 2024
    JKJamuna KrishnanKIKerri Ilene AronsonMMMonika M Safford
    PMID: 38079490PMCID: PMC11109915DOIFirst author4 citations
  3. 3
    Chronic obstructive pulmonary diseases (Miami, Fla.) · 2025
    JKJamuna Krishnan
    PMID: 40037280PMCID: PMC12147823DOIeCommonsFirst author

Publications

28 publications

Funding

5 grantsView NIH portfolio on RePORTER ↗

Active

4 grants
  • PI
    COPDHeart: Improving Cardiovascular Health Among Black Adults with COPD
    National Heart, Lung, and Blood Institute · 2024–2029
    K23HL175204-03
  • Co-I
    Detecting respiratory distress in nursing home patients with advanced ADRD using radio sensors
    National Institute on Aging · 2024–2027
    R21AG081902-01A1
  • PI
    Living Healthy with COPD: An Intervention to Reduce Chronic Pain Integrated Into COPD-Self Management
    American Lung Association, Incorporated · 2024–2027
    ALA 241216-02
  • KP
    Center to Improve Chronic disease Outcomes through Multi-level and Multi-generational approaches Unifying Novel Interventions and Training for health EquitY (Investigator Development Core)
    National Institute on Minority Health and Health Disparities · 2021–2027 · via Columbia University
    No publications yet
    P50MD017341-05
Completed grants (1)
  • Co-I
    Detecting respiratory distress in patients with advanced ADRD using radio sensors
    National Institute on Aging · 2022–2024 · via University of Pennsylvania
    No publications yet
    P30AG073105-02

Clinical research

4 studies

Active

3 studies
  • PI
    COPDHeart: User-Centered Design Study
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
  • PI
    A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease (THARROS)
    PHASE3 · AstraZeneca, PLC · OPEN TO ACCRUAL (as of 2025)
    COPD (Chronic Obstructive Pulmonary Disease)
    NCT06283966
  • PI
    Living Healthy with COPD
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2024)
Completed & closed trials (1)
  • PI
    Perspectives on COPDHeart Intervention Development
    Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)